1. 7 Assessing melanoma BRAF status through ddPCR of cfDNA. Issue 1130 (21st November 2019) Authors: Passy, Lauren; Silva, Shobha; Brock, Ian; Wells, Greg; Cox, Angela; Danson, Sarah Journal: Postgraduate medical journal Issue: Volume 95:Issue 1130(2019) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. (June 2022) Authors: Fennell, Dean A.; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela Journal: EClinicalMedicine Issue: Volume 48(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. (October 2018) Authors: Chouaid, Christos; Danson, Sarah; Andreas, Stefan; Siakpere, Obukohwo; Benjamin, Laure; Ehness, Rainer; Dramard-Goasdoue, Marie-Hélène; Barth, Janina; Hoffmann, Hans; Potter, Vanessa; Barlesi, Fabrice; Price, Mark; Chirila, Costel; Hollis, Kelly; Sweeney, Carolyn; Wolowacz, Sorrel; Kaye, James A.... Journal: Lung cancer Issue: Volume 124(2018) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis of clinical outcomes of extensive stage small-cell lung cancer patients treated with atezolizumab at Weston Park Hospital. (March 2022) Authors: Bagchi, Shaun; Bates, Emma; Danson, Sarah; Das, Tathagata; Fisher, Trish; Hatton, Matthew; Mathew, Tony; Taylor, Fiona; Young, Robin; Lee, Caroline Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial. (January 2023) Authors: Peters, Solange; Letovanec, Igor; Mauer, Murielle; Dafni, Urania; Ejedepang, Dunson; Biernat, Wojciech; Bubendorf, Lukas; Warth, Arne; Pokharel, Saraswati; Reinmuth, Niels; Majem Tarruella, Margarita; Casas-Martin, Jose; Tsourti, Zoi; Marti, Nesa; Kammler, Roswitha; Danson, Sarah; O'Brien, Mary; ... Journal: Lung cancer Issue: Volume 175(2023) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating cell-free DNA copy-number profiles as a biomarker in melanoma. Issue 11 (November 2016) Authors: Silva, Shobha; Teare, Dawn; Bradford, James; Brock, Ian; Connley, Daniel; Jarratt, Emilie; Cramp, Helen; Taylor, Fiona; Cox, Angela; Danson, Sarah Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: S245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. (November 2021) Authors: Peters, Solange; Danson, Sarah; Ejedepang, Dunson; Dafni, Urania; Hasan, Baktiar; Radcliffe, Hoi-Shen; Bustin, Frederique; Crequit, Jacky; Coate, Linda; Guillot, Monica; Surmont, Veerle; Rauch, Daniel; Rudzki, Jakob; O'Mahony, Deirdre; Barneto Aranda, Isidoro; Scherz, Amina; Tsourti, Zoi; Roschit... Journal: Lung cancer Issue: Volume 161(2021) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? – Authors' reply. Issue 1 (January 2022) Authors: Fennell, Dean A; Griffiths, Gareth; Ottensmeier, Christian; Hanna, Gerard G; Danson, Sarah; Szlosarek, Peter; Nye, Mavis Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Coping with melanoma‐related worry: a qualitative study of the experiences and support needs of patients with malignant melanoma. Issue 7 (7th February 2015) Authors: Bird, Joanne; Coleman, Patricia; Danson, Sarah Journal: Journal of clinical nursing Issue: Volume 24:Issue 7/8(2015) Page Start: 937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Copy-number profiles from circulating cell-free DNA as a potential biomarker in melanoma. (March 2018) Authors: Silva, Shobha; Cox, Angela; Teare, Dawn; Bradford, James; Brock, Ian; Connley, Dan; Jarratt, Emilie; Parker, Matthew; Cramp, Helen; Danson, Sarah Journal: European journal of surgical oncology Issue: Volume 44:Supplement 1(2018) Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗